Discover
IONS
Ionis Pharmaceuticals, Inc.
55.42
1 x 55.02
1 x 56.19
bid
ask
-
1.52
2.67%
1 @ 04:00 PM
55.47 +0.05 (0.08%)
| Ytd | -29.95% | |
| 1y | 35.70% |
55.37
day range
57.16
40.37
52 week range
86.74
| Open | 56.79 | Prev Close | 56.94 | Low | 55.37 | High | 57.16 | Mkt Cap | 9.21B |
| Vol | 0.00 | Avg Vol | 2.85M | EPS | -1.72 | P/E | -32.22 | Forward P/E | -49.03 |
| Beta | 0.40 | Short Ratio | 5.18 | Inst. Own | 107.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 66.96 | 200-d Avg | 74.65 | 1yr Est | 89.33 |
| Income Statement | |||
| Total Revenue | 267.95M | ||
| Revenues (USD) | 267.95M | ||
| Cost of Revenue | 2.74M | ||
| Gross Profit | 265.21M | ||
| Operating Expenses | 367.50M | ||
| Research and Development Expense | 217.11M | ||
| Selling, General and Administrative Expense | 150.40M | ||
| Operating Income | -102.29M | ||
| Interest Expense | 22.12M | ||
| Income Tax Expense | 1.26M | ||
| Net Income | -114.65M | ||
| Net Income Common Stock | -114.65M | ||
| Net Income Common Stock (USD) | -114.65M | ||
| Consolidated Income | -114.65M | ||
| Earnings per Basic Share | -0.69 | ||
| Earnings per Basic Share (USD) | -0.69 | ||
| Earnings per Diluted Share | -0.69 | ||
| Earning Before Interest & Taxes (EBIT) | -91.26M | ||
| Earning Before Interest & Taxes (USD) | -91.26M | ||
| Weighted Average Shares | 165.42M | ||
| Weighted Average Shares Diluted | 165.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 350.07M | ||
| Cash and Equivalents (USD) | 350.07M | ||
| Investments | 1.70B | ||
| Investments Current | 1.70B | ||
| Trade and Non-Trade Receivables | 58.85M | ||
| Current Assets | 2.49B | ||
| Property, Plant & Equipment Net | 386.69M | ||
| Total Assets | 2.99B | ||
| Total Debt | 1.61B | ||
| Current Liabilities | 315.64M | ||
| Debt Non-Current | 1.61B | ||
| Total Liabilities | 2.55B | ||
| Accumulated Retained Earnings (Deficit) | -2.84B | ||
| Accumulated Other Comprehensive Income | -33.90M | ||
| Shareholders Equity | 439.74M | ||
| Shareholders Equity (USD) | 439.74M | ||
| Assets Non-Current | 503.23M | ||
| Total Debt (USD) | 1.61B | ||
| Deferred Revenue | 136.87M | ||
| Inventory | 50.83M | ||
| Liabilities Non-Current | 2.24B | ||
| Trade and Non-Trade Payables | 47.70M | ||
| Tax Liabilities | 2.88M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.64M | ||
| Net Cash Flow from Financing | -412.29M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 176.68M | ||
| Capital Expenditure | -16.08M | ||
| Issuance (Purchase) of Equity Shares | 20.26M | ||
| Issuance (Repayment) of Debt Securities | -432.55M | ||
| Net Cash Flow from Investing | 23.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 41.73M | ||
| Net Cash Flow from Operations | 565.53M | ||
| Effect of Exchange Rate Changes on Cash | -50.00K | ||
| Share Based Compensation | 45.60M | ||